Skip to main content
. 2015 Summer;19(3):29–36. doi: 10.7812/TPP/14-231

Table 2.

Comorbidity profile of primary hip fracture cohort

Comorbidity parameter No. (%)
Total number in cohort 12,562 (100.0)
Comorbidities (at least 1) 11,648 (92.7)
Number of comorbiditiesa
0 716 (5.7)
1 1395 (11.1)
2 1976 (15.7)
3 2242 (17.9)
4 2068 (16.5)
≥ 5 3967 (31.6)
Specific conditionsb
AIDS 25 (0.2)
Alcohol abuse 498 (4.0)
Chronic blood loss anemia 485 (3.9)
Chronic pulmonary disease 2685 (21.4)
Coagulopathy 961 (7.7)
Congestive heart failure 1943 (15.5)
Deficiency anemias 3696 (29.4)
Depression 1063 (8.5)
Drug abuse 114 (0.9)
Fluid and electrolyte disorders 2769 (22.0)
Hypertension 8887 (70.8)
Hypothyroidism 2462 (19.6)
Liver disease 331 (2.6)
Lymphoma 165 (1.3)
Metastatic cancer 461 (3.7)
Other neurologic disorders 2201 (17.5)
Paralysis 629 (5.0)
Peptic ulcer disease, bleeding 7 (0.1)
Peripheral vascular disease 2515 (20.0)
Psychoses 1513 (12.0)
Pulmonary circulation disease 593 (4.7)
Renal failure 3162 (25.2)
Rheumatoid arthritis/collagen vascular disease 529 (4.2)
Solid tumor without metastasis 381 (3.0)
Valvular disease 1381 (11.0)
Weight loss 1598 (12.7)
a

Missing data in 1.6% (n = 198).

b

Elixhauser comorbidity measures. Diabetes and obesity are omitted from this list because they are obtained from different sources. Diabetes data are obtained from regional diabetic registries, and obesity data are obtained from body mass index measurements. Both comorbidities are included in Table 1.

AIDS = acquired immunodeficiency syndrome.